FDA Adviser Quits Over ‘Probably The Worst’ Approval Decision Of Alzheimer’s Drug

The controversial drug, called Aduhelm, costs $56,000 a year and some patients could face copayments of $11,500 annually.The controversial drug, called Aduhelm, costs $56,000 a year and some patients could face copayments of $11,500 annually.Read More